Market revenue in 2023 | USD 728.4 million |
Market revenue in 2030 | USD 1,165.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Spain formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is one of the most important markets within Europe for medical products. Large-sized companies account only for 8% to 10% of sales, generating approximately 60% of sales for the country. However, small- & mid-sized companies dominate 90% of the market and are responsible for more than 40% of sales.
Most small-sized companies outsource drug formulation development processes to minimize the investment and time involved in the trials, thereby contributing to market growth. Furthermore, an increase in the number of pharma manufacturing and research facilities in the country is anticipated to fuel the demand for drug formulation development services.
For instance, in 2021, AGC, Inc. announced the expansion of its production capabilities and the establishment of a new R&D facility for its pharmaceutical CDMO subsidiary located in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Spain formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account